On Demand Education

Current clinical practice: differential management of uveal melanoma in the era of molecular tumor analyses.

Dec 2014

Aaberg TM, Cook RW, Oelschlager KM, et al.

Next-generation sequencing of uveal melanoma for detection of genetic alterations predicting metastasis.

Apr 2019

Afshar AR, Damato BE, Stewart JM, et al.

Gene Expression Profiling Prognostication of Posterior Uveal Melanoma: Does Size Matter?

Jan 2020

Binkley EM, Bena JF, Davanzo JM, Hinz C, Boldt HC, Singh AD

Gene expression profiling and PRAME status versus tumor-node-metastasis staging for prognostication in uveal melanoma.

Aug 2018

Am J Ophthalmol 2018;195:154–60

Cai L, Paez-Escamilla M, Walter SD, et al.

Independent prognostic significance of gene expression profile class and largest basal diameter of posterior uveal melanomas.

Feb 2016

Am J Ophthalmol 2016;162:20-7e1.

Correa ZM & Augsburger JJ.

Driver mutations in uveal melanoma: associations with gene expression profile and patient outcomes.

Jul 2016

 JAMA Ophthalmol 2016;134(7):728-33.

Decatur CL, Ong, E, Garg, N, et al.

Do largest basal tumor diameter and the American Joint Committee on Cancer’s cancer staging influence prognostication by gene expression profiling in choroidal melanoma.

Aug 2018

Am J Ophthalmol 2018 Nov;195:83–92.

Demirci H, Niziol LM, Ozkurt Z, Slimani N, Ozgonul C, Liu T, et al.

Epigenetic reprogramming and aberrant expression of PRAME are associated with increased metastatic risk in Class 1 and 2 uveal melanomas.

Jul 2016

Oncotarget 2016;7(37): 59209-19.

Field MG, Durante MA, Decatur CL, et al.

Recent developments in prognostic and predictive testing in uveal melanoma.

May 2014

Curr Opin in Ophthalmol 2014;25(3):234-9.

Field MG & Harbour JW.

Instrument gauge and type in uveal melanoma fine needle biopsy: implications for diagnostic yield and molecular prognostication.

Aug 2020

Am J Ophthalmol 2020; online ahead of print.

Klofas LK, Bogan CM, Coogan A, et al.

Collaborative Ocular Oncology Group Report Number 1: Prospective validation of a multi-gene prognostic assay in uveal melanoma.

Aug 2012

Ophthalmology 2012;119: 1596-1603.

Onken MD, Worley LA, Char CH, et al

An accurate, clinically feasible multi-gene expression assay for predicting metastasis in uveal melanoma.

Jul 2010

J Mol Diagn 2010;12(4):461-8.

Onken MD, Worley LA, Tuscan MD, et al.